603538 美诺华
已收盘 12-10 15:00:00
资讯
新帖
简况
美诺华(603538.SH)子公司获得非布司他片药品注册证书
智通财经 · 12-10 17:04
美诺华(603538.SH)子公司获得非布司他片药品注册证书
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，12月03日股价上涨2.16%
证券之星 · 12-03
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，12月03日股价上涨2.16%
美诺华（603538）披露2021年股票期权与限制性股票激励计划预留授予第二个行权期自主行权结果暨股份变动公告，11月25日股价上涨2.25%
证券之星 · 11-25
美诺华（603538）披露2021年股票期权与限制性股票激励计划预留授予第二个行权期自主行权结果暨股份变动公告，11月25日股价上涨2.25%
每周股票复盘：美诺华（603538）将召开2025年第三季度业绩说明会
证券之星 · 11-23
每周股票复盘：美诺华（603538）将召开2025年第三季度业绩说明会
美诺华（603538）披露召开2025年第三季度业绩说明会，11月19日股价下跌3.6%
证券之星 · 11-19
美诺华（603538）披露召开2025年第三季度业绩说明会，11月19日股价下跌3.6%
每周股票复盘：美诺华（603538）决定不向下修正转股价格
证券之星 · 11-16
每周股票复盘：美诺华（603538）决定不向下修正转股价格
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，11月12日股价下跌1.56%
证券之星 · 11-12
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，11月12日股价下跌1.56%
每周股票复盘：美诺华（603538）美诺转债或触向下修正条件
证券之星 · 11-09
每周股票复盘：美诺华（603538）美诺转债或触向下修正条件
美诺华（603538）披露关于“美诺转债”预计满足转股价格向下修正条件的提示性公告，11月05日股价下跌0.87%
证券之星 · 11-05
美诺华（603538）披露关于“美诺转债”预计满足转股价格向下修正条件的提示性公告，11月05日股价下跌0.87%
每周股票复盘：美诺华（603538）Q3净利增5.78%，制剂业务放量
证券之星 · 11-02
每周股票复盘：美诺华（603538）Q3净利增5.78%，制剂业务放量
美诺华：10月28日接受机构调研，上海景林资产管理有限公司、创金合信基金管理有限公司等多家机构参与
证券之星 · 10-29
美诺华：10月28日接受机构调研，上海景林资产管理有限公司、创金合信基金管理有限公司等多家机构参与
美诺华（603538）2025年三季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 10-29
美诺华（603538）2025年三季报简析：营收净利润同比双双增长，应收账款上升
美诺华(603538)9月30日股东户数3.47万户，较上期增加7.22%
证券之星 · 10-28
美诺华(603538)9月30日股东户数3.47万户，较上期增加7.22%
图解美诺华三季报：第三季度单季净利润同比增长5.78%
证券之星 · 10-28
图解美诺华三季报：第三季度单季净利润同比增长5.78%
美诺华(603538.SH)子公司获得厄贝沙坦氢氯噻嗪片药品注册证书
智通财经 · 10-20
美诺华(603538.SH)子公司获得厄贝沙坦氢氯噻嗪片药品注册证书
每周股票复盘：美诺华（603538）决定不向下修正转股价格
证券之星 · 10-19
每周股票复盘：美诺华（603538）决定不向下修正转股价格
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，10月17日股价下跌2.34%
证券之星 · 10-17
美诺华（603538）公司公告不向下修正“美诺转债”转股价格，10月17日股价下跌2.34%
每周股票复盘：美诺华（603538）美诺转债或触向下修正条件
证券之星 · 10-12
每周股票复盘：美诺华（603538）美诺转债或触向下修正条件
每周股票复盘：美诺华（603538）拟撤销监事会并修订公司章程
证券之星 · 09-14
每周股票复盘：美诺华（603538）拟撤销监事会并修订公司章程
美诺华（603538）发布股东大会决议公告，9月11日股价上涨0.66%
证券之星 · 09-11
美诺华（603538）发布股东大会决议公告，9月11日股价上涨0.66%
加载更多
公司概况
公司名称：
宁波美诺华药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-07
主营业务：
宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。
发行价格：
14.03
{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":20.17,"timestamp":1765350001000,"preClose":20.16,"halted":0,"volume":2519453,"delay":0,"changeRate":0.0005,"floatShares":216000000,"shares":221000000,"eps":0.4509,"marketStatus":"已收盘","change":0.01,"latestTime":"12-10 15:00:00","open":20.2,"high":20.25,"low":19.91,"amount":50636800,"amplitude":0.0169,"askPrice":20.17,"askSize":16,"bidPrice":20.16,"bidSize":174,"shortable":0,"etf":0,"ttmEps":0.4509,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765416600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.16,"symbolType":"stock","openAndCloseTimeList":[[1765330200000,1765337400000],[1765342800000,1765350000000]],"highLimit":22.18,"lowLimit":18.14,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":220630566,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":44.732757,"roe":"4.26%","epsLYR":0.31,"committee":0.669776,"marketValue":4450000000,"turnoverRate":0.0117,"status":0,"floatMarketCap":4361000000},"requestUrl":"/m/hq/s/603538","defaultTab":"news","newsList":[{"id":"2590006153","title":"美诺华(603538.SH)子公司获得非布司他片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2590006153","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590006153?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:04","pubTimestamp":1765357451,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，公司全资子公司宁波美诺华天康药业有限公司(以下简称“美诺华天康”)于近日收到国家药品监督管理局(以下简称“国家药监局”)核准签发的非布司他片《药品注册证书》。药品适应症：适用于痛风患者高尿酸血症的长期治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美诺华(603538.SH)子公司获得非布司他片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2588104495","title":"美诺华（603538）公司公告不向下修正“美诺转债”转股价格，12月03日股价上涨2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588104495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588104495?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:08","pubTimestamp":1764770906,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，美诺华报收于20.3元，较前一交易日上涨2.16%，最新总市值为44.79亿元。该股当日开盘19.8元，最高20.3元，最低19.74元，成交额达7946.59万元，换手率为1.84%。公司于2025年12月3日召开第五届董事会第二十次会议，审议通过不向下修正转股价格的议案，决定本次不向下修正转股价格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2586794934","title":"美诺华（603538）披露2021年股票期权与限制性股票激励计划预留授予第二个行权期自主行权结果暨股份变动公告，11月25日股价上涨2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586794934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586794934?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:10","pubTimestamp":1764079850,"startTime":"0","endTime":"0","summary":"截至2025年11月25日收盘，美诺华报收于19.97元，较前一交易日上涨2.25%，最新总市值为44.06亿元。近日，宁波美诺华药业股份有限公司发布关于2021年股票期权与限制性股票激励计划预留授予第二个行权期自主行权结果暨股份变动的公告。公告显示，本次可行权股票期权数量为738,491股，行权期间为2024年12月25日至2025年11月24日。截至2025年11月24日，累计行权278,530股，占可行权总量的37.72%。行权方式为自主行权，行权所得股票于行权日后的第二个交易日上市交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500038777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2585108731","title":"每周股票复盘：美诺华（603538）将召开2025年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585108731","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585108731?lang=zh_cn&edition=full","pubTime":"2025-11-23 01:50","pubTimestamp":1763833822,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，美诺华报收于19.36元，较上周的22.11元下跌12.44%。本周，美诺华11月17日盘中最高价报22.8元。美诺华当前最新总市值42.71亿元，在化学制药板块市值排名114/151，在两市A股市值排名3626/5167。公司董事长兼总经理姚成志、董事会秘书兼财务负责人应高峰及独立董事贝洪俊将出席。说明会主要内容包括公司2025年第三季度经营成果、财务状况等投资者关注的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2584794215","title":"美诺华（603538）披露召开2025年第三季度业绩说明会，11月19日股价下跌3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584794215","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584794215?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:09","pubTimestamp":1763561360,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，美诺华报收于20.37元，较前一交易日下跌3.6%，最新总市值为44.94亿元。该股当日开盘21.1元，最高21.27元，最低20.31元，成交额达1.51亿元，换手率为3.38%。公司近日发布公告称，宁波美诺华药业股份有限公司将于2025年11月27日13:00-14:45通过上海证券交易所上证路演中心举行2025年第三季度业绩说明会，以视频直播和网络互动方式召开。说明会主要内容包括公司2025年第三季度经营成果、财务状况等投资者关注的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2583659726","title":"每周股票复盘：美诺华（603538）决定不向下修正转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2583659726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583659726?lang=zh_cn&edition=full","pubTime":"2025-11-16 02:55","pubTimestamp":1763232910,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，美诺华报收于22.11元，较上周的22.08元上涨0.14%。因公司股票已满足“美诺转债”转股价格向下修正条件，董事会决定不向下修正转股价格。增资完成后，宣城美诺华注册资本由196,078,500元增至384,467,647.06元，公司持股比例由100%变更为51%，安徽美诺华持股49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2582607377","title":"美诺华（603538）公司公告不向下修正“美诺转债”转股价格，11月12日股价下跌1.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582607377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582607377?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:23","pubTimestamp":1762957402,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，美诺华报收于21.45元，较前一交易日下跌1.56%，最新总市值为47.32亿元。该股当日开盘21.8元，最高21.96元，最低21.27元，成交额达1.4亿元，换手率为2.99%。根据近日发布的公告，宁波美诺华药业股份有限公司于2025年11月12日召开第五届董事会第十九次会议，审议通过《关于不向下修正可转换公司债券转股价格的议案》。董事会决定本次不向下修正转股价格。下一触发修正条款的期间自2025年11月13日起重新计算。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2582618258","title":"每周股票复盘：美诺华（603538）美诺转债或触向下修正条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2582618258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582618258?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:30","pubTimestamp":1762630238,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，美诺华报收于22.08元，较上周的23.83元下跌7.34%。本周，美诺华11月3日盘中最高价报23.99元。本周关注点公司公告汇总：截至2025年11月5日，“美诺转债”已有10个交易日收盘价低于转股价格25.68元/股的90%，预计可能触发转股价格向下修正条款。公司公告汇总宁波美诺华药业股份有限公司发布关于“美诺转债”预计满足转股价格向下修正条件的提示性公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2581775463","title":"美诺华（603538）披露关于“美诺转债”预计满足转股价格向下修正条件的提示性公告，11月05日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581775463","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581775463?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:15","pubTimestamp":1762352125,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，美诺华报收于22.78元，较前一交易日下跌0.87%，最新总市值为50.26亿元。公司近日发布关于“美诺转债”预计满足转股价格向下修正条件的提示性公告。若在任意连续三十个交易日内有至少十五个交易日收盘价低于该阈值，将触发转股价格向下修正条款。公司董事会将在条件触发后审议是否修正转股价格，并及时履行信息披露义务。修正方案须经股东大会表决，出席会议股东所持表决权三分之二以上通过方可实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2580475888","title":"每周股票复盘：美诺华（603538）Q3净利增5.78%，制剂业务放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2580475888","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580475888?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:37","pubTimestamp":1762022229,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，美诺华报收于23.83元，较上周的21.83元上涨9.16%。本周，美诺华10月31日盘中最高价报24.0元。股本股东变化截至2025年9月30日，公司股东户数为3.47万户，较6月30日增加2336.0户，增幅7.22%。其中第三季度单季度主营收入4.39亿元，同比上升28.8%；单季度归母净利润4687.02万元，同比上升5.78%；单季度扣非净利润4960.71万元，同比上升51.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2579908474","title":"美诺华：10月28日接受机构调研，上海景林资产管理有限公司、创金合信基金管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2579908474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579908474?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:58","pubTimestamp":1761739128,"startTime":"0","endTime":"0","summary":"mRN药物合作开发方面，公司在CDMO前端合作持续进行，目前处于前期阶段。生产计划严格根据订单情况安排，合理利用产能，有利于降低单位产品所分摊的各项费用，实现了成本优化。PI方面，目前价格处于底部，公司出货量有增量但因价格变化整体保持平稳，预计今年价格保持平稳、量增状态，明后年排除涨价因素出货量仍将保持增长。创新药及创新类大健康产品是布局核心，包括JH389项目及其他创新药合作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09983","BK1258","BK1583","BK0239","BK1542","BK1229","603538"],"gpt_icon":0},{"id":"2579913737","title":"美诺华（603538）2025年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579913737","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579913737?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:13","pubTimestamp":1761689583,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期美诺华发布2025年三季报。截至本报告期末，公司营业总收入11.17亿元，同比上升17.67%，归母净利润9592.54万元，同比上升51.66%。按单季度数据看，第三季度营业总收入4.39亿元，同比上升28.8%，第三季度归母净利润4687.02万元，同比上升5.78%。本报告期美诺华应收账款上升，应收账款同比增幅达46.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"gpt_icon":0},{"id":"2578369299","title":"美诺华(603538)9月30日股东户数3.47万户，较上期增加7.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578369299","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578369299?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:21","pubTimestamp":1761643288,"startTime":"0","endTime":"0","summary":"证券之星消息，近日美诺华披露，截至2025年9月30日公司股东户数为3.47万户，较6月30日增加2336.0户，增幅为7.22%。在化学制药行业个股中，美诺华股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年6月30日至2025年9月30日，美诺华区间涨幅为10.35%，在此期间股东户数增加2336.0户，增幅为7.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2578627875","title":"图解美诺华三季报：第三季度单季净利润同比增长5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578627875","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578627875?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:50","pubTimestamp":1761591011,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华2025年三季报显示，公司主营收入11.17亿元，同比上升17.67%；归母净利润9592.54万元，同比上升51.66%；扣非净利润8635.96万元，同比上升64.66%；其中2025年第三季度，公司单季度主营收入4.39亿元，同比上升28.8%；单季度归母净利润4687.02万元，同比上升5.78%；单季度扣非净利润4960.71万元，同比上升51.29%；负债率49.05%，投资收益893.38万元，财务费用2800.1万元，毛利率33.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"gpt_icon":0},{"id":"2576831241","title":"美诺华(603538.SH)子公司获得厄贝沙坦氢氯噻嗪片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831241","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831241?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:49","pubTimestamp":1760950169,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，公司全资子公司宁波美诺华天康药业有限公司(简称“美诺华天康”)于近日收到国家药品监督管理局(简称“国家药监局”)核准签发的厄贝沙坦氢氯噻嗪片《药品注册证书》。药品适应症：用于治疗原发性高血压。厄贝沙坦氢氯噻嗪是血管紧张素-Ⅱ受体拮抗剂厄贝沙坦和噻嗪类利尿剂氢氯噻嗪组成的复方。氢氯噻嗪和厄贝沙坦复方在其推荐治疗剂量范围内能产生协同降血压作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美诺华(603538.SH)子公司获得厄贝沙坦氢氯噻嗪片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2576046114","title":"每周股票复盘：美诺华（603538）决定不向下修正转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2576046114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576046114?lang=zh_cn&edition=full","pubTime":"2025-10-19 02:58","pubTimestamp":1760813890,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，美诺华报收于21.72元，较上周的22.1元下跌1.72%。本周，美诺华10月17日盘中最高价报22.77元。本周关注点公司公告汇总：美诺华决定不向下修正“美诺转债”转股价格。公司公告汇总宁波美诺华药业股份有限公司于2025年10月17日召开第五届董事会第十七次会议，审议通过《关于不向下修正可转换公司债券转股价格的议案》，表决结果为同意5票，反对0票，弃权0票。董事会审议后决定本次不修正转股价格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2576059933","title":"美诺华（603538）公司公告不向下修正“美诺转债”转股价格，10月17日股价下跌2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576059933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576059933?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:27","pubTimestamp":1760711233,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，美诺华报收于21.72元，较前一交易日下跌2.34%，最新总市值为47.92亿元。该股当日开盘22.05元，最高22.77元，最低21.63元，成交额达1.91亿元，换手率为4.01%。2025年10月17日，公司召开第五届董事会第十七次会议，审议通过《关于不向下修正可转换公司债券转股价格的议案》，决定本次不向下修正“美诺转债”转股价格。下一触发转股价格修正条款的期间从2025年10月20日起重新计算。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2574457731","title":"每周股票复盘：美诺华（603538）美诺转债或触向下修正条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2574457731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574457731?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:08","pubTimestamp":1760206095,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，美诺华报收于22.1元，较上周的21.75元上涨1.61%。本周，美诺华10月10日盘中最高价报22.41元。本周关注点公司公告汇总：“美诺转债”已有连续十个交易日收盘价低于转股价格的90%，可能触发向下修正条款。2025年第三季度共有197名激励对象参与行权。截至2025年9月30日，总股本由219,828,692股增至220,618,314股。修正方案须经股东大会表决通过，且持有本次可转债的股东应回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2567135328","title":"每周股票复盘：美诺华（603538）拟撤销监事会并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2567135328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567135328?lang=zh_cn&edition=full","pubTime":"2025-09-14 03:19","pubTimestamp":1757791149,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，美诺华报收于24.49元，较上周的25.23元下跌2.93%。公司公告汇总：美诺华2025年第一次临时股东大会审议通过撤销监事会并修订《公司章程》的议案。出席股东及代理人共357人，代表有表决权股份60,389,820股，占公司总股本27.3737%。宁波美诺华药业股份有限公司于2025年9月11日召开2025年第一次临时股东大会，会议由董事会召集，董事长姚成志主持，采取现场与网络投票结合方式，表决方式符合《公司法》及《公司章程》规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2566994304","title":"美诺华（603538）发布股东大会决议公告，9月11日股价上涨0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566994304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566994304?lang=zh_cn&edition=full","pubTime":"2025-09-11 22:14","pubTimestamp":1757600065,"startTime":"0","endTime":"0","summary":"截至2025年9月11日收盘，美诺华报收于24.55元，较前一交易日上涨0.66%，最新总市值为53.97亿元。近日，宁波美诺华药业股份有限公司召开2025年第一次临时股东大会，并发布股东大会决议公告。其中，《关于撤销监事会并修订<公司章程>的议案》为特别决议议案，经出席股东所持有效表决权三分之二以上同意通过，其余11项子议案也均获高票通过，同意比例均超过99.7%。本次股东大会未出现否决议案的情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100038720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765413879421,"stockEarnings":[{"period":"1week","weight":-0.0064},{"period":"1month","weight":-0.0815},{"period":"3month","weight":-0.1784},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.4148},{"period":"ytd","weight":0.5907}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0065},{"period":"6month","weight":0.155},{"period":"1year","weight":0.1396},{"period":"ytd","weight":0.1637}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34704人(较上一季度增加7.22%)","perCapita":"6229股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区扬帆路999弄1号1406室","registeredCapital":"22063万元","survey":" 宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}